InsiderTrades.com logo
This Bull Market Indicator called NVDA at $116
From WealthPress   |   Ad
Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…
All you have to do is follow this link here

BCAX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $34,254,000.00
Insider Selling (Last 12 Months): $0.00

Bicara Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Bicara Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bicara Therapeutics Share Price & Price History

Current Price: $18.38
Price Change: ▼ Price Decrease of -0.94 (-4.87%)
As of 11/20/2024 01:00 AM ET

This chart shows the closing price history over time for BCAX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
From Colonial Metals   |   Ad
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…
Claim your FREE 2024 Gold Guide

Bicara Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/17/2024James E FlynnMajor ShareholderBuy70,000$18.00$1,260,000.00897,587View SEC Filing Icon  
9/16/2024Ra Capital Management, L.P.DirectorBuy1,833,000$18.00$32,994,000.004,303,418View SEC Filing Icon  
See Full Table
JD Vance Predicts: Wall Street vs. Trump & Your Money
From Priority Gold   |   Ad
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Get your free guide NOW before it's too late.

SEC Filings (Institutional Ownership Changes) for Bicara Therapeutics (NASDAQ:BCAX)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BCAX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Bicara Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC10,000$0.26M0.0%N/A0.018%Search for SEC Filing on Google Icon
11/18/2024Teachers Retirement System of The State of Kentucky14,039$0.36M0.0%N/A0.026%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC48,639$1.24M0.0%N/A0.094%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC10,000$0.26M0.0%N/A0.019%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC12,151$0.31M0.0%N/A0.023%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP763,943$19.46M0.0%N/A1.476%Search for SEC Filing on Google Icon
11/15/2024Soros Fund Management LLC20,000$0.51M0.0%N/A0.039%Search for SEC Filing on Google Icon
11/15/2024Samsara BioCapital LLC35,000$0.89M0.2%N/A0.068%Search for SEC Filing on Google Icon
11/15/2024RA Capital Management L.P.6,955,993$177.17M2.0%N/A13.439%Search for SEC Filing on Google Icon
11/15/2024Point72 DIFC Ltd55,757$1.42M0.0%N/A0.108%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.371,962$9.47M0.0%N/A0.719%Search for SEC Filing on Google Icon
11/15/2024Maven Securities LTD50,000$1.27M0.0%N/A0.097%Search for SEC Filing on Google Icon
11/15/2024Iron Triangle Partners LP200,000$5.09M0.7%N/A0.386%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC1,188,191$30.33M0.0%N/A2.296%Search for SEC Filing on Google Icon
11/15/2024Cinctive Capital Management LP9,001$0.23M0.0%N/A0.017%Search for SEC Filing on Google Icon
11/15/2024Baker BROS. Advisors LP833,333$21.23M0.2%N/A1.610%Search for SEC Filing on Google Icon
11/15/2024Point72 Asia Singapore Pte. Ltd.18,125$0.46M0.1%N/A0.035%Search for SEC Filing on Google Icon
11/14/2024Braidwell LP1,657,600$42.22M1.2%N/A3.202%Search for SEC Filing on Google Icon
11/14/2024Vestal Point Capital LP425,000$10.83M0.8%N/A0.821%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC31,780$0.81M0.0%N/A0.061%Search for SEC Filing on Google Icon
11/13/2024FMR LLC2,273,792$57.91M0.0%N/A4.393%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 22,859$0.58M0.0%N/A0.044%Search for SEC Filing on Google Icon
11/7/2024First Turn Management LLC562,391$14.32M2.3%N/A1.087%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Bicara Therapeutics logo
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Read More on Bicara Therapeutics

Today's Range

Now: $18.38
Low: $17.62
High: $20.79

50 Day Range

MA: $23.16
Low: $19.00
High: $27.07

52 Week Range

Now: $18.38
Low: $17.62
High: $28.09

Volume

361,884 shs

Average Volume

360,589 shs

Market Capitalization

$1.00 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Bicara Therapeutics?

Bicara Therapeutics' top insider shareholders include:
  1. Ra Capital Management, LP (Director)
  2. James E Flynn (Major Shareholder)
Learn More about top insider investors at Bicara Therapeutics.

Who are the major institutional investors of Bicara Therapeutics?

Bicara Therapeutics' top institutional investors include:
  1. RA Capital Management L.P. — 13.44%
  2. FMR LLC — 4.39%
  3. Braidwell LP — 3.20%
  4. Janus Henderson Group PLC — 2.30%
  5. Baker BROS. Advisors LP — 1.61%
  6. Wellington Management Group LLP — 1.48%
Learn More about top institutional investors of Bicara Therapeutics stock.

Which major investors are buying Bicara Therapeutics stock?

During the last quarter, BCAX stock was purchased by institutional investors including:
  1. RA Capital Management L.P.
  2. FMR LLC
  3. Braidwell LP
  4. Janus Henderson Group PLC
  5. Baker BROS. Advisors LP
  6. Wellington Management Group LLP
  7. First Turn Management LLC
  8. Vestal Point Capital LP
In the last year, these company insiders have bought Bicara Therapeutics stock:
  1. Ra Capital Management, LP (Director)
  2. James E Flynn (Major Shareholder)
Learn More investors buying Bicara Therapeutics stock.
This Bull Market Indicator called NVDA at $116
From WealthPress   |   Ad
Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…
All you have to do is follow this link here